Anzeige
Mehr »
Login
Donnerstag, 12.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Der zukünftige Solana-ETF, unterstützt von BlackRock, Fidelity & dem Rest der Wall Street!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 906866 | ISIN: US0231351067 | Ticker-Symbol: AMZ
Tradegate
12.12.24
17:45 Uhr
218,45 Euro
-0,95
-0,43 %
1-Jahres-Chart
AMAZON.COM INC Chart 1 Jahr
5-Tage-Chart
AMAZON.COM INC 5-Tage-Chart
RealtimeGeldBriefZeit
218,35218,4517:45
218,35218,4017:45
ACCESSWIRE
71 Leser
Artikel bewerten:
(0)

Nitches, Inc.: Nitches Inc. Updates Shareholders on Amazon Store Launch and Online Sales Growth for InTheZone Labs Products

Finanznachrichten News

MIAMI, FL / ACCESSWIRE / December 12, 2024 / Nitches Inc. (OTC PINK:NICH) is excited to announce the official placement of its first InTheZone Labs product, InTheZone Focused Extreme, on Amazon. As part of our aggressive online growth strategy, this marks a pivotal moment for the company as we expand our reach into one of the largest e-commerce platforms globally. The Amazon listing is live and available for purchase here: https://a.co/d/ggjrEED

Amazon: A Powerhouse for Nutraceuticals Growth

Amazon has established itself as a dominant sales channel for nutraceuticals and dietary supplements, with the category experiencing record growth in recent years. According to market research, the global nutraceuticals market is projected to reach $620.3 billion by 2030, driven by a surge in consumer demand for health-focused products. Nutraceutical brands on Amazon often generate millions in annual revenue, and some achieve significant success without a dedicated corporate website.

For Nitches Inc., this strategic move into Amazon provides a powerful growth vehicle. Our vision is to capitalize on Amazon's vast customer base, seamless logistics network, and trusted marketplace reputation. This represents a major milestone in our plan to scale InTheZone Labs into a globally recognized brand.

InTheZone Labs Products: Meeting Consumer Demand for Science-Backed Wellness

Our Amazon store launch begins with InTheZone Focused Extreme, the flagship nootropic and nutraceutical supplement designed to boost mental clarity, cognitive support, and sustained energy. This premium formulation includes bioceutical-grade ingredients such as Alpha-GPC, Lion's Mane Mushroom, and Omega-3 DHA, all designed to help users unlock their full potential.

In the coming weeks, we plan to expand the Amazon catalog with two additional products:

1. InTheZone Focused Youth: A cognitive support supplement tailored for younger users seeking sharper focus and mental stamina, enriched with brain-boosting ingredients like Phosphatidylserine and Bacopa Monnieri.
2. InTheZone Passion: A vitality-enhancing supplement for men that supports hormonal balance, libido, and energy levels, featuring clinically backed ingredients such as Tribulus Terrestris and Fenugreek.

Each product is crafted in FDA-compliant, GMP-certified facilities in the United States, reflecting our commitment to quality, safety, and transparency.

Next Steps and Exciting Developments

Our team is actively working with Amazon to enhance product pages, optimize listings, and integrate advanced marketing campaigns. Next week, we plan to announce an exciting development that will further accelerate the growth of InTheZone Labs' online sales and brand visibility.

Why This Matters for Shareholders

Nitches' online rapid growth strategy is showing tangible results. As we expand the InTheZone Labs presence on Amazon, we are tapping into a proven revenue channel. Many nutraceutical brands have built multi-million-dollar businesses solely through Amazon's marketplace, leveraging its vast audience and streamlined logistics to scale rapidly.

The nutraceuticals and nootropics categories are experiencing unprecedented demand as consumers increasingly prioritize health, wellness, and cognitive enhancement. InTheZone Labs is well-positioned to capture market share with its science-backed, American-made products. Our commitment to constant updates, high-quality formulations, and strategic partnerships underscores our long-term vision of growth and profitability.

FDA Disclaimer:

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with your healthcare provider before starting any new dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.

For additional updates, shareholders are encouraged to follow our progress at www.inthezonelabs.com

For media inquiries, please contact:
John Morgan
Public Relations Lead
Nitches Inc.

Nitches Inc. remains committed to driving shareholder value through strategic innovation, expanding our market footprint, and building brands that make an impact.

Contact Information

John Morgan
Ceo
info@nitchescorp.com

SOURCE: Nitches, Inc.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.